http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080112090-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_597a4b4c9078b464871e1e66470aab36 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-075 |
| filingDate | 2008-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8510db3d3e5f3ad38d1b6fac346c4611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bac268cda7748e67240196a7961a26d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f08e2d6f621ecc7fb03b785b11ede80d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_310b9893af04fea66549c040fe791ae5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1307aeb779784b84680bfe19c43102a |
| publicationDate | 2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20080112090-A |
| titleOfInvention | Pharmaceutical composition for the prevention and treatment of diabetes or PIA-gamma-mediated diseases comprising nutmeg adenocarcinoma extract compound |
| abstract | The present invention relates to a pharmaceutical composition for preventing and treating diabetes comprising the nutmeg alfalfa extract compound as an active ingredient, and more particularly, 2- (4-allyl-2,6-dime, which is a compound extracted from the apiary skin of nutmeg The present invention relates to a pharmaceutical composition for preventing and treating diabetes comprising oxyphenoxy) -1- (4-hydroxy-3-methoxyphenyl) -propane, austobirignan 7 or lycarin E as an active ingredient. 2- (4-allyl-2,6-dimethoxyphenoxy) -1- (4-hydroxy-3-methoxyphenyl) -propane, austobairignan 7 and lycarin E of the present invention are nutmeg It is a compound isolated from the extract of aril of nutmeg, and the compound and nutmeg alfalfa extract acts as a ligand of PPARγ to activate PPARγ and thus can be used for the purpose of preventing and treating diseases such as diabetes and diabetic complications mediated by PPARγ. Can be. See also 2- (4-allyl-2,6-dimethoxyphenoxy) -1- (4-hydroxy-3-methoxyphenyl) -propane, austobirignan 7, lycarin E, and nutmeg arithmetic nutmeg) extract can also be used as a preventive and therapeutic agent for diabetes by reducing blood sugar. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010140734-A1 |
| priorityDate | 2007-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 254.